Curis
CRIS
#11024
Rank
โ‚ฌ0.59 M
Marketcap
0,30ย โ‚ฌ
Share price
-17.89%
Change (1 day)
-80.36%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚ฌ1.17 Million

According to Curis's latest financial reports the company's total debt is โ‚ฌ1.17 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ1.37 M-51.48%
2024-12-31โ‚ฌ2.83 M12.31%
2023-12-31โ‚ฌ2.52 M-31.21%
2022-12-31โ‚ฌ3.67 M-17.44%
2021-12-31โ‚ฌ4.45 M-28.56%
2020-12-31โ‚ฌ6.22 M4103.78%
2019-12-31โ‚ฌ0.14 M-99.52%
2018-12-31โ‚ฌ31.01 M-10.44%
2017-12-31โ‚ฌ34.63 M83.43%
2016-12-31โ‚ฌ18.88 M-14.57%
2015-12-31โ‚ฌ22.1 M-5.02%
2014-12-31โ‚ฌ23.26 M5.17%
2013-12-31โ‚ฌ22.12 M-1.92%
2012-12-31โ‚ฌ22.55 M
2008-12-31N/A-100%
2007-12-31โ‚ฌ0.27 M-81.57%
2006-12-31โ‚ฌ1.5 M-69.53%
2005-12-31โ‚ฌ4.92 M-2.53%
2004-12-31โ‚ฌ5.05 M12.41%
2003-12-31โ‚ฌ4.49 M-62.17%
2002-12-31โ‚ฌ11.87 M-0.75%
2001-12-31โ‚ฌ11.96 M83.99%
2000-12-31โ‚ฌ6.5 M382.37%
1999-12-31โ‚ฌ1.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚ฌ55.89 B 4,766,541.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.71 B 3,472,450.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ25.29 M 2,057.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.14 B 12,580.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ1.67 M 42.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ7.46 M 536.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B 42,802.02%๐Ÿ‡บ๐Ÿ‡ธ USA